Compare Indonesia Prima Property Tbk (OMRE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesia Prima Property Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Indonesia Prima Property Tbk trades at Rp935 (market cap 2.81T, 7.5K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indonesia Prima Property Tbk is far larger — about 26.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| OMRE | SCPI | |
|---|---|---|
Market Cap | 2.81T | 104.4B |
Volume | 7.5K | — |
Lot | 75 | — |
Turnover | 6.71M | — |
Average Price | 894.67 | — |
Value | 6.71M | — |
Indicative Equilibrium Price | 935 | — |
Indicative Equilibrium Volume | 2 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indonesia Prima Property Tbk
PT Indonesia Prima Property Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on notarial deed No. 31 dated April 23, 1983 of Sastra Kosasih, S.H., notary in Surabaya. PT Ometraco Realty, is a member of the Ometraco Group. The company operates in developing and managing apartments, office properties, hotels and shopping centers.
Read more on OMRE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
